Article Text

other Versions

Download PDFPDF
Novel SOD1 mutation discovered in atypical ALS by whole exome sequencing
  1. Christopher J Klein1,2,
  2. Yanhong Wu3,
  3. Xiaohui Duan1,
  4. Sumit Middha4,
  5. Brian D Dawson3,
  6. Jean-Pierre Kocher4,
  7. Peter J Dyck1
  1. 1Department of Neurology, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA
  2. 2Department of Medical Genetics, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA
  3. 3Department of Laboratory Medicine and Pathology, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA
  4. 4Department of Bioinformatics and Statistics, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA
  1. Correspondence to Dr Christopher J Klein, Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA; klein.christopher{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


Patients with familial amyotrophic lateral sclerosis (f-ALS) typically have asymmetric onset weakness, upper motor neuron signs, absent sensory involvement and relatively rapid disease progression with fatality typically in 2–5 years of onset.1 In contrast, distal hereditary motor neuropathies (dHMNs) and hereditary motor and sensory neuropathies type-2 (HMSN2) have symmetric length-dependent motor axonal loss and slow disease onset and progression. Hereditary motor neuropathies and motor neuron diseases have extremely diverse genetic causes,1 ,2 and within each group, distinct phenotype–genotype correlations are uncommon for f-ALS, dHMN and HMSN2.

This report illustrates a varied phenotypic presentation from SOD1-associated f-ALS and illustrates whole exome sequencing (WES) as an effective approach for diagnosing genetically heterogeneous disorders with atypical phenotypes.


Human subjects

The study was approved by our institutional review board. Participants consented to use their medical records and DNA materials in research studies.

Case report

The proband was evaluated at ages 39, 40, 43, 65, 67 and 73 years. He had symmetrical progressive distal weakness of legs with foot drop and foot paraesthesias. Weakness progressed to his hands. Ankle reflexes were absent, and vibration sensation was reduced at the toes. Babinski and Chaddock signs were absent. From 39 to 65 years of age, he was suspected to have dHMN or HMSN. By age 67, spinobulbar muscular atrophy (SBMA) and HMSN2C were also considered in the differential diagnosis because of weakness in bulbar musculature, flaccid dysarthria and dysphagia. His reflexes became brisk at patellar and biceps brachii tendons despite the prominent weakness in the …

View Full Text


  • Contributors CJK: study concept and design, study supervision, acquisition, analysis and interpretation of data, drafting and revising the manuscript. YW, XD, SM, J-PK, PJD: study concept and design, revising manuscript, acquisition, analysis and interpretation of data.

  • Funding NIH NS065007, Centre for Individualised Medicine of Mayo Clinic, Mayo Center For Translational Science Activities.

  • Competing interests None.

  • Ethics approval Mayo Clinic Internal Review Board.

  • Provenance and peer review Not commissioned; externally peer reviewed.